Sparking a Revolution in Intelligent Care
The Rising T1DE Alliance (Rising T1DE) was launched in 2020 through a $8.5 million grant from The Leona M. and Harry B. Charitable Trust to Children’s Mercy Hospital Kansas City to rapidly innovate and scale quality improvement efforts in diabetes care by leveraging predictive analytics technology developed by Cyft. Rising T1DE harnesses data overlooked by much of the healthcare ecosystem, combining machine learning and human expertise to illuminate systemic insight across the entire care journey. The project is led by Dr. Mark Clements at Children’s Mercy along with collaborators Dr. Leonard D’Avolio at Cyft, Dr. Susana Patton at Nemours Children’s Health, Dr. Ryan McDonough at Children’s Mercy, and Dr. Sanjeev Mehta at the Joslin Diabetes Center.
Under the strategic direction of a multidisciplinary Stakeholder Advisory Committee comprised of individuals with expertise in Type 1 diabetes research and quality improvement, data science, patient perspectives, communications, dissemination, and healthcare entrepreneurship, the Rising T1DE strives to advance diabetes care one intervention at a time. The goal of the Rising T1DE is simple: get in front of problems by predicting clinically important outcomes, curating and evaluating novel interventional strategies to help individuals with diabetes achieve better health and quality of life, and creating a platform to drive rapid-cycle testing of novel behavioral, digital and care delivery interventions using implementation science.
The Rising T1DE Alliance aims to increase the rate of deployment of successful interventions and innovative therapies in diabetes care by identifying an outcome to target, developing a prediction model, testing interventions, and in a fully transparent manner, sharing learnings and guidance with other clinicians and health systems.